United States Biopsy (Breast, Prostate, Lung, Liver & Thyroid) Market will Surpass US$ 17 Billion by 2024

Posted on 2018-02-21 by Mark Hub in Healthcare, Pharmaceuticals // 0 Comments

Albany, US, 2018-Feb-21 — /EPR Network/ — An up-to-date research report has been disclosed by Market Research Hub highlighting the title “United States Biopsy Market” provides a complete analysis of the United States Biopsy Market and Volume. United States Biopsy Market will cross US$ 17 Billion by the year 2024 owing to the rising prevalence of cancer in the region. According to the World Health Organization, cancer cases are expected to surge 57% worldwide in the next 20 years. Biopsies are most often done to look for cancer; a biopsy is a sample of tissue taken from the body in order to examine it more closely. Further, growing patient awareness and the advancement in the biopsy techniques are also expected to fuel future growth of biopsy market in United States.

Request For Free Sample Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=1572616

The World Cancer Report, produced by the WHO’s specialized cancer agency and released on World Cancer Day, predicts new cancer cases will rise from an estimated 14 million annually in 2012 to 22 million within two decades. Over the same period, cancer deaths are predicted to rise from 8.2 million a year to 13 million.

By Segment – United States Biopsy Market and Volume
On a segment basis, Breast cancer biopsies account for the highest share in the United States Biopsy Market for the year 2017. While, in terms of Volume, Breast cancer biopsy has a second highest share. Further, the report also covers the market aspects of Liver, Lung and Thyroid cancer biopsies. The United States Biopsy Market and Volume will experience a major growth during the forecast period owing to the increasing number of biopsy procedures and rising demand for minimally invasive procedures

All the 8 companies studied in the report have been studied from 4 points
Overview
Business Strategy
Merger & Acquisition
Financial Insight

Segments Covered in the Report:
Breast Cancer Biopsy
Prostate Cancer Biopsy
Lung Cancer Biopsy
Liver Cancer Biopsy
Thyroid Cancer Biopsy

Key Companies Covered in the Report:
C. R. Bard, Inc.
Becton, Dickinson and Company
B. Braun Melsungen AG
Cardinal Health, Inc.
Olympus Corporation
FUJIFILM Holdings Corporation
Medtronic plc.
Hologic, Inc

Browse Full Report with TOC: https://www.marketresearchhub.com/report/united-states-biopsy-market-volume-forecast-by-segments-breast-prostate-lung-liver-thyroid-companies-report.html

United States – Biopsy Testing Market – Overview
United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the United States. However if we make the analysis from the Volume point then Prostate Cancer is the most popular segment. Increasing United States prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period.

The United States Biopsy Market has been analyzed from two viewpoints
United States Biopsy Test Market & Forecast (2008 – 2020)
United States Biopsy Test Volume & Forecast (2008 – 2020)

The Top 5 Cancer Segments covered are:
Breast Cancer
Prostate Cancer
Liver Cancer
Lung Cancer
Thyroid Cancer

Enquire About This Report: https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1572616

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of In vitro diagnostics research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick